{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:24:58Z","timestamp":1770884698368,"version":"3.50.1"},"reference-count":127,"publisher":"Informa UK Limited","issue":"2","funder":[{"name":"Internal Granting Agency of the Ministry of Health of the Czech Republic","award":["NS 10 364-363\/2009"],"award-info":[{"award-number":["NS 10 364-363\/2009"]}]},{"name":"Research Project of the Institute of Hematology and Blood Transfusion","award":["MZOUHKT2005"],"award-info":[{"award-number":["MZOUHKT2005"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.2217\/imt.10.2","type":"journal-article","created":{"date-parts":[[2010,3,5]],"date-time":"2010-03-05T17:00:45Z","timestamp":1267808445000},"page":"227-241","source":"Crossref","is-referenced-by-count":14,"title":["Immunotherapy of Chronic Myeloid Leukemia: Present State and Future Prospects"],"prefix":"10.1080","volume":"2","author":[{"given":"Vladim\u00edr","family":"Vonka","sequence":"first","affiliation":[{"name":"Department of Experimental Virology, Institutute of Hematology & Blood Transfusion, U nemocnice 1, 128 20 Prague 2, Czech Republic. Tel.: Fax:"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2010,3,5]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0022-3565(24)38879-2","article-title":"Abl protein-tyrosine kinase inhibitor ST171 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.","volume":"295","author":"Buchdunger E","year":"2000","unstructured":"Buchdunger E , CioffiCL, LawNet al.: Abl protein-tyrosine kinase inhibitor ST171 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.J. Pharmacol. Exp. Ther.295 , 137\u2013145 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441402"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.5.1758.005a41_1758_1766"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402741"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03256446"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1099480"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.01.007"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/14653240802317639"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401703"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e32831bc38a"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.268"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3181837276"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.8.3118.3118"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.9.3362"},{"key":"e_1_3_2_3_16_1","first-page":"3863","article-title":"HLA-B8 and HLA-A3 coexpressed with HLA B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBHT.","volume":"93","author":"Posthuma EF","year":"1999","unstructured":"Posthuma EF , FalkenburgJH, ApperleyJFet al.: HLA-B8 and HLA-A3 coexpressed with HLA B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBHT.Blood93 , 3863\u20133865 (1999).","journal-title":"Blood"},{"key":"e_1_3_2_3_17_1","first-page":"137","volume":"6","author":"Khosravi F","year":"2007","unstructured":"Khosravi F , AmirzargarA, SarafnejadA et al: HLA class II allele and haplotype frequencies in Iranian patients with leukemia. Iran J. Allergy Asthma Immunol.6 , 137\u2013142 (2007).","journal-title":"Iran J. Allergy Asthma Immunol."},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802668873"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.157.2.522"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/79526"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0659"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0981"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.433"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-153825"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.10.2680.bloodjournal85102680"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.9.3587.bloodjournal8793587"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.9.3522.bloodjournal8893522"},{"key":"e_1_3_2_3_28_1","first-page":"1344","article-title":"Recognition of peptides corresponding to the joining region of p210BCR\u2013ABL protein by human T cells.","volume":"9","author":"ten Bosch GJ","year":"1995","unstructured":"ten Bosch GJ , ToornvlietAC, FriedeT, MeliefCJ, LeeksmaOC: Recognition of peptides corresponding to the joining region of p210BCR\u2013ABL protein by human T cells.Leukemia9 , 1344\u20131348 (1995).","journal-title":"Leukemia"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.6.2118.bloodjournal8862118"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401311"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1054\/blre.2000.0127"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI488"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.10.2887"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-002-0362-7"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.12.8210"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.148"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2868"},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0302"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-071001"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M202789200"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0861"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-1956"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2761"},{"key":"e_1_3_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-005-0036-7"},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.7.7.881"},{"key":"e_1_3_2_3_46_1","first-page":"5529","article-title":"A putative oncogenic role for MPP11 in head and neck squamous cell cancer.","volume":"60","author":"Resto VA","year":"2000","unstructured":"Resto VA , CaballeroOL, ButaMRet al.: A putative oncogenic role for MPP11 in head and neck squamous cell cancer.Cancer Res.60 , 5529\u20135535 (2000).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1102\/1470-7330.2004.0006"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-170282"},{"key":"e_1_3_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00982.x"},{"key":"e_1_3_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1650"},{"key":"e_1_3_2_3_51_1","first-page":"5517","article-title":"CML 28 is broadly immunogenic antigen, which is expressed in tumor cells.","volume":"62","author":"Yang XF","year":"2002","unstructured":"Yang XF , WuCJ, ChenLet al.: CML 28 is broadly immunogenic antigen, which is expressed in tumor cells.Cancer Res.62 , 5517\u20135522 (2002).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.04.035"},{"key":"e_1_3_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-2538"},{"key":"e_1_3_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi001603q"},{"key":"e_1_3_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4704"},{"key":"e_1_3_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005541114029"},{"key":"e_1_3_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01053.x"},{"key":"e_1_3_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-179697"},{"key":"e_1_3_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2009.10.001"},{"key":"e_1_3_2_3_60_1","doi-asserted-by":"publisher","DOI":"10.1586\/epr.09.71"},{"key":"e_1_3_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/PL00006680"},{"key":"e_1_3_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-7843com"},{"key":"e_1_3_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2229"},{"key":"e_1_3_2_3_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209477"},{"key":"e_1_3_2_3_65_1","first-page":"183","article-title":"Vaccination with leukemia-loaded dendritic cells eradicates residual diseases and prevent relapse.","volume":"5","author":"Deeb D","year":"2006","unstructured":"Deeb D , GaoX, JiangH, DivineG, DulchavskySA, GautamBC: Vaccination with leukemia-loaded dendritic cells eradicates residual diseases and prevent relapse.J. Exp. Ther. Oncol.5 , 183\u2013193 (2006).","journal-title":"J. Exp. Ther. Oncol."},{"key":"e_1_3_2_3_66_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.18.6558"},{"key":"e_1_3_2_3_67_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.23.9312"},{"key":"e_1_3_2_3_68_1","first-page":"12","article-title":"Characteristics of two mouse bcr-abl-transformed cell lines I. General properties of the cells.","volume":"51","author":"Sobotkov\u00e1 E","year":"2005","unstructured":"Sobotkov\u00e1 E , Ludv\u00edkov\u00e1V, Petr\u00e1\u010dkov\u00e1Met al.: Characteristics of two mouse bcr-abl-transformed cell lines I. General properties of the cells.Folia Biol. (Praha)51 , 12\u201318 (2005).","journal-title":"Folia Biol. (Praha)"},{"key":"e_1_3_2_3_69_1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.14712\/fb2005051040093","article-title":"Characteristics of two mouse bcr-abl-transformed cell lines. II. Pathological lesions induced in mice.","volume":"51","author":"Jel\u00ednek F","year":"2005","unstructured":"Jel\u00ednek F , Sobotkov\u00e1E, VonkaV: Characteristics of two mouse bcr-abl-transformed cell lines. II. Pathological lesions induced in mice.Folia Biol. (Praha)51 , 93\u2013102 (2005).","journal-title":"Folia Biol. (Praha)"},{"key":"e_1_3_2_3_70_1","first-page":"941","article-title":"DNA vaccination against bcr-abl- transfornmed cells in mice.","volume":"35","author":"Lucansk\u00fd V","year":"2009","unstructured":"Lucansk\u00fd V , Sobotkov\u00e1E, TachezyR, Du\u0161kov\u00e1M, VonkaV: DNA vaccination against bcr-abl- transfornmed cells in mice.Int. J. Oncol.35 , 941\u2013951 (2009).","journal-title":"Int. J. Oncol."},{"key":"e_1_3_2_3_71_1","first-page":"1247","volume":"35","author":"Hru\u0161kov\u00e1 V","year":"2009","unstructured":"Hru\u0161kov\u00e1 V , Mor\u00e1vkov\u00e1A, BabiarovaK et al: Bcr-Abl fusion sequences do not induce immune responses in mice when administered in mouse polyomavirus based virus-like particles. Int. J. Oncol.35 , 1247\u20131256 (2009).","journal-title":"Int. J. Oncol."},{"key":"e_1_3_2_3_72_1","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2009_03_194"},{"key":"e_1_3_2_3_73_1","first-page":"793","article-title":"Combined chemo- and immunotherapy of tumors induced in mice by bcr-abl-transformed cells.","volume":"21","author":"Sobotkov\u00e1 E","year":"2009","unstructured":"Sobotkov\u00e1 E , Du\u0161kov\u00e1M, TachezyR, PetrackovaM, VonkaV: Combined chemo- and immunotherapy of tumors induced in mice by bcr-abl-transformed cells.Oncol. Rep.21 , 793\u2013799 (2009).","journal-title":"Oncol. Rep."},{"key":"e_1_3_2_3_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2005.11.028"},{"key":"e_1_3_2_3_75_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-156471"},{"key":"e_1_3_2_3_76_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.14712\/fb2006052030047","article-title":"Immunological profiles of patients with chronic myeloid leukaemia I. State before the start of treatment.","volume":"52","author":"Humlov\u00e1 Z","year":"2006","unstructured":"Humlov\u00e1 Z , Klamov\u00e1H, Janatkov\u00e1Iet al.: Immunological profiles of patients with chronic myeloid leukaemia I. State before the start of treatment.Folia Biol. Prague)52 , 47\u201358 (2006).","journal-title":"Folia Biol. Prague)"},{"key":"e_1_3_2_3_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-009-0733-4"},{"key":"e_1_3_2_3_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0536-z"},{"key":"e_1_3_2_3_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03669"},{"key":"e_1_3_2_3_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603310"},{"key":"e_1_3_2_3_81_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.1.319"},{"key":"e_1_3_2_3_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1487"},{"key":"e_1_3_2_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2005.06.028"},{"key":"e_1_3_2_3_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603603"},{"key":"e_1_3_2_3_85_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0501870102"},{"key":"e_1_3_2_3_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201999"},{"key":"e_1_3_2_3_87_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.2064"},{"key":"e_1_3_2_3_88_1","first-page":"635","article-title":"Targeting Bcl-2 protein expression in solid tumors and haematological malignancies with antisense oligonucleotides.","volume":"3","author":"Tolcher A","year":"2005","unstructured":"Tolcher A : Targeting Bcl-2 protein expression in solid tumors and haematological malignancies with antisense oligonucleotides.Clin. Adv. Hematol. Oncol.3 , 635\u2013642 (2005).","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"e_1_3_2_3_89_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190902943069"},{"key":"e_1_3_2_3_90_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-164889"},{"key":"e_1_3_2_3_91_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-128397"},{"key":"e_1_3_2_3_92_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000095"},{"key":"e_1_3_2_3_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.5.1781.005k46_1781_1787"},{"key":"e_1_3_2_3_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(03)00011-0"},{"key":"e_1_3_2_3_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402979"},{"key":"e_1_3_2_3_96_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2003.1.331"},{"key":"e_1_3_2_3_97_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0954"},{"key":"e_1_3_2_3_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17945-8"},{"key":"e_1_3_2_3_99_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0250"},{"key":"e_1_3_2_3_100_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404858"},{"key":"e_1_3_2_3_101_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06547.x"},{"key":"e_1_3_2_3_102_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-108241"},{"key":"e_1_3_2_3_103_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24468"},{"key":"e_1_3_2_3_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.7"},{"key":"e_1_3_2_3_105_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.10.3835"},{"key":"e_1_3_2_3_106_1","first-page":"2675","article-title":"A Pr1- human antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelologenous leukemia.","volume":"59","author":"Millerem JJ","year":"1999","unstructured":"Millerem JJ , LeePP, WangC, ChamplinRE, DavisMM: A Pr1- human antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelologenous leukemia.Cancer Res.59 , 2675\u20132681 (1999).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2006.07.009"},{"key":"e_1_3_2_3_108_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.161"},{"key":"e_1_3_2_3_109_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2363"},{"key":"e_1_3_2_3_110_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402732"},{"key":"e_1_3_2_3_111_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-009-0675-x"},{"key":"e_1_3_2_3_112_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-144071"},{"key":"e_1_3_2_3_113_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.193.1.73"},{"key":"e_1_3_2_3_114_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-150045"},{"key":"e_1_3_2_3_115_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-164889"},{"key":"e_1_3_2_3_116_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-006-0152-8"},{"key":"e_1_3_2_3_117_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2008.00823.x"},{"key":"e_1_3_2_3_118_1","first-page":"1119","volume":"30","author":"Chen J","year":"2007","unstructured":"Chen J , SchmittA, BunjesD et al: The receptor for hyaluronic acid-mediated motility induces specific CD8+ T cell response in healthy donors and patients with chronic myeloid leukemia after allogenic stem cell transplantation. Int. J. Oncol.30 , 1119\u20131127 (2007).","journal-title":"Int. J. Oncol."},{"key":"e_1_3_2_3_119_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500052131"},{"key":"e_1_3_2_3_120_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.11.5391"},{"key":"e_1_3_2_3_121_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.107"},{"key":"e_1_3_2_3_122_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2548"},{"key":"e_1_3_2_3_123_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.4.2709"},{"key":"e_1_3_2_3_124_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-023127"},{"key":"e_1_3_2_3_125_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-2538"},{"key":"e_1_3_2_3_126_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.7.12.7219"},{"key":"e_1_3_2_3_127_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2046"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.10.2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T01:20:32Z","timestamp":1739928032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.10.2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":127,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.2217\/imt.10.2"],"URL":"https:\/\/doi.org\/10.2217\/imt.10.2","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}